Ισραήλ - Εβραϊκά - Ministry of Health

dr.samuelov importing & marketing ltd - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water - סירופ - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water 417 mg/ml

Ισραήλ - Εβραϊκά - Ministry of Health

vetmarket marketing ltd - diethanolamine fusidate 5 mg; framycetin sulfate 5 mg - drops - for the treatment of otitis externa in dogs and cats including otodectes cynotis.

Ισραήλ - Εβραϊκά - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Ισραήλ - Εβραϊκά - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus

Ισραήλ - Εβραϊκά - Ministry of Health

cts ltd - patiromer as sorbitex calcium - אבקה להכנת תרחיף - patiromer as sorbitex calcium 16.8 g - patiromer calcium

Ισραήλ - Εβραϊκά - Ministry of Health

cts ltd - patiromer as sorbitex calcium - אבקה להכנת תרחיף - patiromer as sorbitex calcium 8.4 g - patiromer calcium

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - טבליה - methylphenidate hydrochloride 20 mg - methylphenidate

Ισραήλ - Εβραϊκά - Ministry of Health

גילקו פארם בעמ - קרם להקלה לעור אדמומי מגורה, לשפתיים יבשות וסדוקות, לעור סדוק ויבש

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 5 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 10 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.